LetterLetter
Open Access

Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis

Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali and Sunny H. Wong
Cancer Biology & Medicine July 2026, 20250841; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0841

References

  1. 1.↵
    2. Sung H,
    3. Ferlay J,
    4. Siegel RL,
    5. Laversanne M,
    6. Soerjomataram I,
    7. Jemal A, et al.
    Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2021; 71: 209–49.
    OpenUrlCrossRefPubMed
  2. 2.↵
    2. Demark-Wahnefried W,
    3. Rogers LQ,
    4. Gibson JT,
    5. Harada S,
    6. Frugé AD,
    7. Oster RA, et al.
    Randomized trial of weight loss in primary breast cancer: impact on body composition, circulating biomarkers and tumor characteristics. Int J Cancer. 2020; 146: 2784–96.
    OpenUrlPubMed
  3. 3.↵
    2. Bahrami A,
    3. Haghighi S,
    4. Moghani MM,
    5. Khodakarim N,
    6. Hejazi E.
    Fasting mimicking diet during neo-adjuvant chemotherapy in breast cancer patients: a randomized controlled trial study. Front Nutr. 2024; 11: 1483707.
  4. 4.
    2. Demark-Wahnefried W,
    3. Rais-Bahrami S,
    4. Desmond RA,
    5. Gordetsky JB,
    6. Hunter GR,
    7. Yang ES, et al.
    Presurgical weight loss affects tumour traits and circulating biomarkers in men with prostate cancer. Br J Cancer. 2017; 117: 1303–13.
    OpenUrlPubMed
  5. 5.
    2. de Groot S,
    3. Vreeswijk MP,
    4. Welters MJ,
    5. Gravesteijn G,
    6. Boei JJ,
    7. Jochems A, et al.
    The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer. 2015; 15: 652.
    OpenUrlCrossRefPubMed
  6. 6.
    2. de Groot S,
    3. Lugtenberg RT,
    4. Cohen D,
    5. Welters MJP,
    6. Ehsan I,
    7. Vreeswijk MPG, et al.
    Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial. Nat Commun. 2020; 11: 3083.
    OpenUrlCrossRefPubMed
  7. 7.↵
    2. Li JH,
    3. Han L,
    4. Du TP,
    5. Guo MJ.
    The effect of low-nitrogen and low-calorie parenteral nutrition combined with enteral nutrition on inflammatory cytokines and immune functions in patients with gastric cancer: a double blind placebo trial. Eur Rev Med Pharmacol Sci. 2015; 19: 1345–50.
    OpenUrlPubMed
  8. 8.
    2. Lugtenberg RT,
    3. de Groot S,
    4. Kaptein AA,
    5. Fischer MJ,
    6. Kranenbarg EMK,
    7. Carpentier MD, et al.
    Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial. Breast Cancer Res Treat. 2021; 185: 741–58.
    OpenUrlCrossRefPubMed
  9. 9.
    2. Riedinger CJ,
    3. Kimball KJ,
    4. Kilgore LC,
    5. Bell CW,
    6. Heidel RE,
    7. Boone JD.
    Water only fasting and its effect on chemotherapy administration in gynecologic malignancies. Gynecol Oncol. 2020; 159: 799–803.
    OpenUrlCrossRefPubMed
  10. 10.↵
    2. Zuccoli G,
    3. Marcello N,
    4. Pisanello A,
    5. Servadei F,
    6. Vaccaro S,
    7. Mukherjee P, et al.
    Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: case report. Nutr Metab (Lond). 2010; 7: 33.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section